SAMJIN PHARMACEUTICAL CO.,LTD Logo

SAMJIN PHARMACEUTICAL CO.,LTD

Researches, develops, manufactures, and sells OTC and prescription medicines.

005500 | KO

Overview

Corporate Details

ISIN(s):
KR7005500004
LEI:
Country:
South Korea
Address:
서울특별시 마포구 와우산로 121 삼진제약사옥, 마포구

Description

Samjin Pharmaceutical Co., Ltd. is a pharmaceutical company engaged in the research, development, manufacturing, and sale of medicines. The company's portfolio includes a wide range of over-the-counter (OTC) and prescription drugs, offered in various formulations such as oral, drop, and injectable forms. Notable products include the analgesic Gevorin, the antiplatelet agent Plavix, and the hypercholesterolemia treatment Newstatin-R. A central part of its strategy is a strong commitment to R&D, focusing on creating innovative new drugs to address diseases with high unmet medical needs. The company actively develops novel therapeutics for severe conditions, including cardiovascular, respiratory, and gastrointestinal diseases, with the goal of becoming a global pharmaceutical innovator.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-08-29 00:00
주식등의대량보유상황보고서(일반)
Korean 126.6 KB
2025-08-27 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.0 KB
2025-08-21 00:00
주식등의대량보유상황보고서(일반)
Korean 126.6 KB
2025-08-14 00:00
반기보고서 (2025.06)
Korean 1.1 MB
2025-07-29 00:00
주식등의대량보유상황보고서(일반)
Korean 96.6 KB
2025-07-21 00:00
주식등의대량보유상황보고서(일반)
Korean 96.6 KB
2025-07-07 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean 25.1 KB
2025-05-15 00:00
분기보고서 (2025.03)
Korean 1.1 MB
2025-05-12 00:00
주요사항보고서(자기주식취득신탁계약해지결정)
Korean 27.9 KB
2025-05-12 00:00
신탁계약해지결과보고서
Korean 18.4 KB
2025-03-21 00:00
정기주주총회결과
Korean 25.7 KB
2025-03-21 00:00
사외이사의선임ㆍ해임또는중도퇴임에관한신고
Korean 11.2 KB
2025-03-21 00:00
대표이사(대표집행임원)변경(안내공시)
Korean 5.7 KB
2025-03-13 00:00
감사보고서제출
Korean 11.3 KB
2025-03-13 00:00
사업보고서 (2024.12)
Korean 1.4 MB

Automate Your Workflow. Get a real-time feed of all SAMJIN PHARMACEUTICAL CO.,LTD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SAMJIN PHARMACEUTICAL CO.,LTD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SAMJIN PHARMACEUTICAL CO.,LTD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Advicenne Logo
A specialty pharmaceutical company developing treatments for rare renal diseases.
France
ALDVI
AegirBio AB Logo
A diagnostics company specializing in therapeutic drug monitoring for biological drugs.
Sweden
AEGIR
Aelis Farma Logo
Biopharmaceutical company developing CB1 receptor inhibitors for CNS disorders.
France
AELIS
AEON Biopharma, Inc. Logo
Clinical-stage company developing therapeutic applications for botulinum toxins.
United States of America
AEON
AFC-HD AMS Life Science Co.,Ltd. Logo
An OEM of health foods, supplements, and cosmetics with integrated R&D and manufacturing.
Japan
2927
AGENUS INC Logo
A clinical-stage biotechnology company specializing in immuno-oncology therapies.
United States of America
AGEN
AGIOS PHARMACEUTICALS, INC. Logo
Biopharmaceutical company developing therapies for rare and genetically defined diseases.
United States of America
AGIO
AHN-GOOK PHARMACEUTICAL Co., Ltd. Logo
Develops and markets medicines, focusing on respiratory and cardiovascular treatments.
South Korea
001540
Akari Therapeutics Plc Logo
Develops next-gen antibody-drug conjugates using proprietary cancer-killing toxins.
United States of America
AKTX
Akebia Therapeutics, Inc. Logo
A biopharmaceutical company that develops and commercializes therapeutics for kidney disease.
United States of America
AKBA

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.